4.5 Article

Adipose-Derived Mesenchymal Stem Cells Promote M2 Macrophage Phenotype through Exosomes

期刊

STEM CELLS INTERNATIONAL
卷 2019, 期 -, 页码 -

出版社

HINDAWI LTD
DOI: 10.1155/2019/7921760

关键词

-

资金

  1. National Research Foundation of Korea (NRF) - Korea government (MSIT) [2019R1C1C1007036]
  2. National Research Foundation of Korea [2019R1C1C1007036] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

向作者/读者索取更多资源

Accumulating evidence has shown that the paracrine factors derived from mesenchymal stem cells (MSCs) are capable of regulating the immune system via interaction with various immune cells. In this study, adipose-derived MSCs (AdMSCs) and human peripheral blood monocytes (PBMCs) were isolated and cultured to examine the effects of MSC-induced macrophages (iM phi) on inflammation and immune modulation. Indirect coculture with MSCs increased the expression of arginase-1 and mannose receptor (CD206), markers of activated M2 macrophages, in the PBMCs demonstrating that MSC-secreted factors promoted M2-M phi polarization. Additionally, iM phi exhibited a similar higher inhibitory effect on the growth of activated T cells compared to that in the other groups (AdMSCs only, AdMSCs plus iM phi), implying that iM phi can play a sufficient functional role. Interestingly, the population of FoxP3 Treg cells significantly increased when cocultured with iM phi, suggesting that iM phi have an immunomodulatory effect on the Treg cells through the modulation of the FoxP3 expression. Notably, iM phi expressed high levels of immunosuppressive and anti-inflammatory cytokines, namely IL-10 and TSG-6. Furthermore, we confirmed that the AdMSC-derived exosomes modulated macrophage polarization by upregulating the expression of M2 macrophage markers. Conclusively, our results suggest that iM phi play a significant role in regulating the immunomodulatory- and inflammatory-mediated responses. Thus, iM phi may be used as a novel stem cell-based cell-free therapy for the treatment of immune-mediated inflammatory disorders.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据